Synergy Spine Solutions® Receives FDA Approval for its Synergy Disc®, Expanding Cervical Disc Replacement Options for U.S. Patients

Synergy Spine Solutions®, a medical device company focused on improving the quality of life for patients undergoing spine surgery, today announced it has received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) for the Synergy Disc® for 1-level indications at C3-C7.

The Synergy Disc is a unique motion-preserving artificial cervical disc designed to treat patients with degenerative disc disease (DDD) of the cervical spine. It is the first and only artificial cervical disc designed to improve anatomic alignment and to provide intentional motion preservation, using time-tested and trusted materials. FDA approval of the Synergy Disc is supported by clinical evidence generated through a rigorous prospective clinical study conducted under an Investigational Device Exemption (IDE) in the U.S. The company also has over 10 years of clinical experience with the Synergy Disc outside the United States in more than 10 countries, where the device has been commercially available and implanted in thousands of patients.

Sign up for Blog Updates